Managers / Q2 2023 · view latest →
Temasek Holdings (Private) Ltd
CIK 0001021944 · 60B ORCHARD ROAD #06-18, THE ATRIUM@ORCHARD, SINGAPORE, 238891 · 65 6828 6828
Summary
Temasek Holdings (Private) Ltd reported $17.3B in U.S.-listed holdings across 75 positions for Q2 2023.
The portfolio is heavily concentrated: BLKCHF alone accounts for 20.4% of reported value.
Compared with Q1 2023, the fund opened 12 new positions and exited 18.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 76.6% · $13.2B
- ADR · 19.4% · $3.3B
- ETP · 2.8% · $477M
- Other · 1.3% · $224M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ISHARES TR | NEW | +805.0K | 805.0K | +$151M | $151M |
| GLOBAL E ONLINE LTD | NEW | +2.11M | 2.11M | +$86M | $86M |
| NOWSERVICENOW INC | NEW | +84.6K | 84.6K | +$48M | $48M |
| MUMICRON TECHNOLOGY INC | NEW | +208.2K | 208.2K | +$13M | $13M |
| PCORPROCORE TECHNOLOGIES INC | NEW | +84.6K | 84.6K | +$6M | $6M |
| GTLBGITLAB INC | NEW | +66.0K | 66.0K | +$3M | $3M |
| MLB1MERCADOLIBRE INC | NEW | +2.2K | 2.2K | +$3M | $3M |
| ORCHARD THERAPEUTICS PLC | NEW | +352.4K | 352.4K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $30.5B | 152 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $31.6B | 146 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $29.0B | 129 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $26.2B | 131 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $24.8B | 128 | May 16, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $25.4B | 135 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $24.7B | 121 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $21.5B | 90 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $18.1B | 101 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $17.9B | 101 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $16.8B | 82 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $17.3B | 75 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $16.7B | 81 | May 15, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2022 | $17.1B | 72 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $16.7B | 82 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $18.3B | 97 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $23.7B | 96 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $27.7B | 95 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $29.9B | 99 | Nov 15, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2021 | $34.3B | 99 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $25.5B | 71 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $23.3B | 71 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $19.7B | 67 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $16.7B | 52 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $13.6B | 58 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $15.3B | 53 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $13.6B | 52 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $14.0B | 53 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $14.4B | 50 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $14.5B | 58 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 30 additional managers.
- Sheares Healthcare Group Pte. Ltd.028-21884
- Alberta Investments Pte. Ltd.028-22962
- Anderson Investments Pte. Ltd.028-19221
- Aranda Investments Pte. Ltd.028-17255
- Bartley Investments Pte. Ltd.028-19228
- Birchtree Fund Investments Private Ltd028-20817
- Canhill Investments Pte. Ltd.028-13098
- Dahlia Investments Pte. Ltd.028-15196
- Dunearn Investments (Mauritius) Pte Ltd028-14160
- Ellington Investments Pte. Ltd.028-19227
- Esta Investments Pte. Ltd.028-15912
- Evans Investments Pte. Ltd.028-17259
- Everitt Investments Pte. Ltd.028-19226
- Fullerton Fund Investments Pte Ltd028-15193
- Fullerton Management Pte Ltd028-13103
- Havelock Fund Investments Pte Ltd028-15197
- Hotham Investments Pte. Ltd.028-20818
- Ixora Investments Pte. Ltd.028-17256
- Munday Investments Pte. Ltd.028-15904
- Napier Investments Pte. Ltd.028-19225
- Ossa Investments Pte. Ltd.028-20819
- Seletar Investments Pte Ltd028-13095
- Sherwood Investments Pte. Ltd.028-14803
- Temasek Capital (Private) Ltd028-13090
- Temasek Life Sciences Private Ltd028-15907
- Tembusu Capital Pte. Ltd.028-14163
- Thomson Capital Pte. Ltd.028-15195
- TLS Beta Pte. Ltd.028-19223
- Venezio Investments Pte. Ltd.028-19222
- V-Sciences Investments Pte Ltd028-15905
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.